<SEC-DOCUMENT>0001144204-18-028188.txt : 20180514
<SEC-HEADER>0001144204-18-028188.hdr.sgml : 20180514
<ACCEPTANCE-DATETIME>20180514161136
ACCESSION NUMBER:		0001144204-18-028188
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20180514
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20180514
DATE AS OF CHANGE:		20180514

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Precipio, Inc.
		CENTRAL INDEX KEY:			0001043961
		STANDARD INDUSTRIAL CLASSIFICATION:	LABORATORY ANALYTICAL INSTRUMENTS [3826]
		IRS NUMBER:				911789357
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36439
		FILM NUMBER:		18830702

	BUSINESS ADDRESS:	
		STREET 1:		12325 EMMET ST
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164
		BUSINESS PHONE:		4027385480

	MAIL ADDRESS:	
		STREET 1:		12325 EMMET STREET
		CITY:			OMAHA
		STATE:			NE
		ZIP:			68164

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	TRANSGENOMIC INC
		DATE OF NAME CHANGE:	20000119
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>tv494064_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 1pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>UNITED STATES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SECURITIES AND EXCHANGE COMMISSION<BR>
WASHINGTON, D. C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-right: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>FORM 8-K </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>CURRENT REPORT</B><BR>
<B>PURSUANT TO SECTION 13 OR 15(d) OF THE</B><BR>
<B>SECURITIES EXCHANGE ACT OF 1934 </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Date of report (Date of earliest event reported):
May 14, 2018</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>PRECIPIO,
INC.</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(Exact Name of Registrant as Specified in Its Charter)</I></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><FONT STYLE="font-size: 10pt"><I>&nbsp;</I></FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>Delaware</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(State of Incorporation)</I></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>001-36439</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(Commission File Number)</I></FONT></TD>
    <TD STYLE="width: 2%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><FONT STYLE="font-size: 10pt"><B>91-1789357</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><I>(I.R.S. Employer Identification No.)</I></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>4 Science Park, New Haven, CT 06511</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Address of principal executive offices)
(Zip Code)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(203) 787-7888</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>(Registrant's telephone number, including
area code)</I></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-right: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Not Applicable</B><BR>
<I>(Former name, former address and former fiscal year, if changed since last report date)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-right: 0; margin-top: 0; margin-bottom: 0"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 15%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction
A.2. below):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) </FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD><FONT STYLE="font-size: 10pt">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of
1933 (&sect;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&sect;240.12b-2 of this chapter).</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">Emerging
growth company <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a)
of the Exchange Act. <FONT STYLE="font-family: Wingdings">&#168;</FONT></P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0pt; margin-bottom: 0pt; font: 10pt Times New Roman, Times, Serif"></P>




<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 1in; text-align: left"><B>Item 2.02</B></TD><TD STYLE="text-align: justify"><B>Results of Operations and Financial Conditions.</B></TD>
</TR></TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">On May 14, 2018, the Company issued a press
release announcing its preliminary, unaudited revenue for the first quarter of 2018. A copy of the press release issued by the
Company is furnished as Exhibit 99.1 to this report.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 22.5pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The information in this Current Report on&nbsp;Form&nbsp;8-K&nbsp;furnished
under this Item&nbsp;2.02 including Exhibit 99.1 is furnished and shall not be deemed &ldquo;filed&rdquo; for any purpose, including
for the purposes of Section&nbsp;18 of the Securities Exchange Act of 1934, as amended (the &ldquo;<U>Exchange Act</U>&rdquo;),
or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any other filing
under the Exchange Act or under the Securities Act, regardless of any general incorporation language in such filing.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B>&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 1in; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt"><B>Item&nbsp;9.01</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&#9;<FONT STYLE="font-size: 10pt"><B>Financial Statements and Exhibits.</B></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-size: 10pt">(d)</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-size: 10pt">Exhibits.</FONT></TD>
</TR></TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 12%; border-bottom: black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibit</B></FONT><BR>
<FONT STYLE="font-size: 10pt"><B>No.</B></FONT></TD>
    <TD STYLE="width: 3%; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 85%; border-bottom: black 1pt solid; text-align: center"><FONT STYLE="font-size: 10pt"><B>Description</B></FONT></TD></TR>
<TR STYLE="vertical-align: bottom">
    <TD STYLE="padding-bottom: 1pt"><A HREF="tv494064_ex99-1.htm" STYLE="-sec-extract: exhibit">99.1&#9;</A></TD>
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; text-align: left"><A HREF="tv494064_ex99-1.htm" STYLE="-sec-extract: exhibit">Press Release dated May 14, 2018&nbsp;</A></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SIGNATURE </B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt"><B>PRECIPIO, INC.</B></FONT></TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="width: 50%; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; width: 6%; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">By:</FONT></TD>
    <TD STYLE="vertical-align: top; width: 30%; border-bottom: black 1pt solid; padding: 0; text-indent: 0">/s/ Ilan Danieli</TD>
    <TD STYLE="width: 14%; padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Name:</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">Ilan Danieli</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0"><FONT STYLE="font-size: 10pt">Title:</FONT></TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">Chief Executive Officer</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
<TR>
    <TD STYLE="padding: 0; text-indent: 0">Date:&#9;May 14, 2018&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="vertical-align: top; padding: 0; text-indent: 0">&nbsp;</TD>
    <TD STYLE="padding: 0; text-indent: 0">&nbsp;</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 3; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>tv494064_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"><B>Exhibit 99.1</B></P>

<P STYLE="margin: 0; text-align: right"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><IMG SRC="image_001.jpg" ALT="">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Precipio Announce<FONT STYLE="color: #222222">s
Preliminary Q</FONT>1 2018 Year-over-Year Revenue Increase of 286%</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>&nbsp;</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><I>Growth resulting from commercial team
reorganization, product and service cross-selling, and increased business stabilization</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>NEW HAVEN, CT, (May 14<SUP>th</SUP>, 2018) &ndash; </B>Specialty
diagnostics company <FONT STYLE="color: #1155CC">Precipio, Inc.</FONT> (<FONT STYLE="color: #1155CC">NASDAQ:PRPO</FONT>), announces
preliminary, unaudited 1<SUP>st</SUP> quarter 2018 revenues of approximately $712,000, representing a 286% increase from the same
quarter in the prior year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Drivers of revenue growth that have been completed in Q1 2018
include:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>a restructured and expanded sales staff, including a new VP of sales, and sales reps with years of directly relevant industry
sales experience</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>dedication of separate sales infrastructure to pathology services and ICE COLD PCR&trade; (ICP) / Pharma projects</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">&#9679;</TD><TD>increased cross-selling of pathology services with ICP lung cancer treatment resistance panel as well as others</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The sequential decrease from <FONT STYLE="color: #1155CC">Q4
2017</FONT>&rsquo;s revenues was due to that quarter&rsquo;s catch up of backlog resulting from prior months&rsquo; lab closing
and relocation from Omaha to our headquarters in New Haven, CT. Q1 2018 revenues represent what we feel is a more normalized growth
trend resulting from the stabilization of operations following a year of financial and corporate restructuring.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;With the completion of our sales reorganization and increasing
business stabilization, we are focused on aggressively capturing market share with our disruptive diagnostic products and services,&rdquo;
commented Ilan Danieli, CEO. &ldquo;The growth we are experiencing in Q1 reflects the strides being made by our sales team and
the improved business activity resulting from our initiatives.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>About Precipio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">Precipio has built a platform designed
to eradicate the problem of misdiagnosis by harnessing the intellect, expertise and technology developed within academic institutions
and delivering quality diagnostic information to physicians and their patients worldwide. Through its collaborations with world-class
academic institutions specializing in cancer research, diagnostics and treatment, initially the Yale School of Medicine, Precipio
offers a new standard of diagnostic accuracy enabling the highest level of patient care. For more information, please visit www.precipiodx.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Disclaimer</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The financial data for the quarter ended March 31, 2017 set
forth above is preliminary and is based on information available to management as of the date of this press release and is subject
to completion by management of Precipio&rsquo;s financial statements. Precipio&rsquo;s independent registered public accountants
have not audited, reviewed or performed any procedures with respect to such preliminary financial data and accordingly do not express
an opinion or any other form of assurance with respect thereto.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify">&nbsp;<B>Forward-Looking Statements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Certain statements in this press release constitute &ldquo;forward-looking
statements,&rdquo; within the meaning of federal securities laws, including statements related to ICP technology, including other
financial projections and potential market opportunity, plans and prospects and other statements containing the words &ldquo;anticipate,&rdquo;
&ldquo;intend,&rdquo; &ldquo;may,&rdquo; &ldquo;plan,&rdquo; &ldquo;predict,&rdquo; &ldquo;will,&rdquo; &ldquo;would,&rdquo; &ldquo;could,&rdquo;
&ldquo;should,&rdquo; and similar expressions, constitute forward-looking statements within the meaning of The Private Securities
Litigation Reform Act of 1995. The Company's actual results could differ materially from those anticipated in these forward-looking
statements as a result of various factors. Factors that could cause future results to materially differ from the recent results
or those projected in forward-looking statements include the known risks, uncertainties and other factors described in the Company&rsquo;s
Annual Report on Form 10-K for the year ended December 31, 2017, the Company&rsquo;s prior filings and from time to time in the
Company&rsquo;s subsequent filings with the Securities and Exchange Commission. Any change in such factors, risks and uncertainties
may cause the actual results, events and performance to differ materially from those referred to in such statements. All information
in this press release is as of the date of the release and the Company does not undertake any duty to update this information,
including any forward-looking statements, unless required by law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Inquiries</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1155CC"><B><U>investors@precipiodx.com</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; color: #1155CC"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>+1-203-787-7888</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; background-color: white"><B>&nbsp;</B></P>



<P STYLE="margin: 0"></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>image_001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 image_001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !$ 5P# 2(  A$! Q$!_\0
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M^,_-B1\:H<;E!QRU<T$K-OH;LM?\+>\(?\_EQ_X#/_A1_P +>\(?\_=Q_P"
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MD?DH_I7C9X%?0/A#3&TCPM86CC$HCWR#_:;YC_/'X5V8R5H)&5)>]<VZ\_\
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CY('W&_\ BJZC5]8NK*^\F'9MV@_,N:**TJ12:LB8-M:G_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
